Dean Monti,Fran Hackler 2015-07-31 00:19:45
It felt appropriate that the AAD’s Leadership/Corporate Partner Circle Summit, on June 25-26, was in Washington, D.C. – the seat of leadership and decision-making in our nation. The Summit focused on urgent issues facing the specialty, pharma and patients. The audience of AAD leadership, industry, staff and invited speakers addressed the mercurial landscape of healthcare and its implications on the specialty and the patients they serve. Led by David Pariser, MD, outgoing chair of corporate relations task force and C. William Hanke, MD, incoming chair, the Summit began with an update on the discussions that took place at the 2014 meeting. Dr. Pariser informed attendees about the new DermCare Team affiliation launched at the AAD Annual Meeting in San Francisco earlier this year. The affiliation allows AAD members to enroll their care teams, including physician assistants, nurse practitioners, nurses, and medical assistants. Dr. Pariser also described the new educational, non-member category. AAD fellows, associates, and affiliate DOs can choose whether they would like to enroll their staff in the AAD DermCare Team, he said, recapping the progress of the newly launched affiliation. After the updates, the group delved into several key issues from different perspectives – where healthcare has been, where it is now, and where it’s going. The quick-changing healthcare landscape was evident when the group was discussing ACA, MACRA, and the Supreme Court, just as the ruling on King v. Burwell came down confirming that the ACA is not going anywhere. After a robust dialogue on the first day, attendees gained further insight the second day with a host of “Hot Topics.” These topics addressed the speculated future of innovation and regulation (including ACA, Sunshine Act, etc.) in healthcare. Notably, Ester Banque, vice president and head of immunology & dermatology, US general medicines at Novartis Pharmaceuticals Corporation, gave an inspiring “Corner Office Perspective” titled, “Uniting for the Benefit of Patients,” that envisioned a future of advancements and innovation for the benefit of improved patient outcomes. Healthcare could become more tailored to an individual’s needs; health payers could act as coaches promoting better health choices; and that technology continues to change lives and societies. Following each panel, attendees engaged in lively dialogue drawing on their own experience and expertise. These subsequent discussions prompted a strong and renewed commitment to address issues and collaborate where possible. While some plans are already well underway, there is a desire to continue to partner with industry to meet new and emerging challenges.
Published by American Academy Of Dermatology. View All Articles.